文献速递创面修复显微修复重建

终末期肾病糖尿病足:血管成形联合游离皮瓣重建

Diabetic Foot Preservation in End-Stage Renal Disease with Combined Angioplasty and Free Flap Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2025-10-09

回顾性队列研究纳入2010至2022年台湾35例透析糖尿病足患者共40条患肢,行血管内再通后游离皮瓣重建。皮瓣成功率92.5%,1、2、5年保肢率分别为97%、91.9%、83.5%,但患者1、2、5年生存率仅65%、46%、21.6%。

要点

  • 透析糖尿病足行血管成形联合游离皮瓣,皮瓣成功率92.5%,5年保肢率83.5%。
  • 年龄、吸烟史、脑卒中史与重大截肢风险升高相关。
  • 高保肢率未转化为生存获益,5年生存率仅21.6%。

核心结论

  • 终末期肾病糖尿病足患者行游离皮瓣重建可靠且保肢率高,但5年内未改善患者生存。

研究设计与样本

  • 回顾性队列研究,纳入台湾大林慈济医院2010年1月至2022年1月透析糖尿病足伴外周动脉闭塞及软组织缺损行血管内再通后游离皮瓣重建者,共35例患者40条患肢。

主要发现

  • 中位随访559.5天,皮瓣成功率92.5%。
  • 1、2、5年保肢率分别为97%、91.9%、83.5%。
  • 患者1、2、5年生存率分别为65%、46%、21.6%。
  • 年龄(P=0.043)、吸烟史(P=0.026)、脑卒中史(P=0.0003)与重大截肢风险升高相关。

临床怎么用

  • 对透析糖尿病足伴外周动脉闭塞及软组织缺损者,可考虑血管内再通后游离皮瓣重建以保肢。
  • 术前应评估年龄、吸烟史及脑卒中史等截肢风险因素。
  • 需向患者说明高保肢率不等于生存改善,5年生存率仅21.6%。

局限性

  • 回顾性单中心设计,样本量小(35例40条患肢),中位随访559.5天,长期生存结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic foot disease is a significant global health problem, contributing to poor wound healing and an increased risk of lower extremity amputation. These challenges are exacerbated in patients with diabetes and end-stage renal disease (ESRD). There is limited evidence on the long-term efficacy of combined angioplasty and free flap reconstruction for limb preservation in the diabetic ESRD population. The authors report the long-term outcomes of this limb preservation approach. METHODS: A retrospective cohort study was conducted in patients with diabetes receiving hemodialysis who had peripheral arterial occlusive disease and soft-tissue defects of the foot. Patients who underwent endovascular revascularization followed by free flap reconstruction for lower limb preservation at Dalin Tzu Chi General Hospital, Taiwan, from January of 2010 through January of 2022 were included. The primary objective was to report outcomes in this cohort. The secondary objective was to identify risk factors for flap loss, lower limb amputation, and death. RESULTS: The authors analyzed 40 legs of 35 patients who underwent the combined procedure. The median follow-up was 559.5 days. The flap success rate was 92.5%. The 1-, 2-, and 5-year limb preservation rates were 97%, 91.9%, and 83.5%, respectively. Patient survival rates at 1, 2, and 5 years were 65%, 46%, and 21.6%. Age ( P = 0.043), smoking history ( P = 0.026), and cerebrovascular accident history ( P = 0.0003) were associated with higher risks of major limb amputation. CONCLUSIONS: Free flap reconstruction for diabetic foot disease in patients with ESRD is reliable and has a high limb preservation rate. However, this may not translate to improved patient survival over a 5-year period.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hsu H, Chan J, Cheng YT, et al. Diabetic Foot Preservation in End-Stage Renal Disease with Combined Angioplasty and Free Flap Reconstruction. Plast Reconstr Surg. 2025. PMID: 41071275. doi:10.1097/PRS.0000000000012515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。